Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
09/2014
09/04/2014US20140249159 Heterocyclic compounds
09/04/2014US20140249144 Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient
09/04/2014US20140249139 Quinazoline Derivatives
09/04/2014US20140249134 Triazolyl pde10 inhibitors
09/04/2014US20140249133 Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases
09/04/2014US20140249129 Substituted Bicyclic Dihydropyrimidinones And Their Use As Inhibitors Of Neutrophil Elastase Activity
09/04/2014US20140249128 Triazine carboxamides as sodium channel blockers
09/04/2014US20140249127 Serine/threonine kinase inhibitors
09/04/2014US20140249104 Perfluorinated 5,6-dihydro-4h-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
09/04/2014US20140248378 Pyrimidinone compounds and their use
09/04/2014US20140248299 Vinyl-phenyl derivatives for inflammation and immune-related uses
09/03/2014EP2772492A1 Use of an isoxazole derivative for the treatment of withdrawal symptom
09/03/2014EP2772490A1 Aminoalkyl-substituted n-thienyl benzamide derivative
09/03/2014EP2772486A1 Kinase inhibitor and method for treatment of related diseases
09/03/2014EP2772485A1 Bicyclic compound
09/03/2014EP2771338A2 1, 2, 4 - oxadiazole derivatives as ethr inhibitors for use in the treatment tuberculosis
09/03/2014EP2771337A1 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
09/03/2014EP2771334A1 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies
09/03/2014EP2771332A1 Hiv protease inhibitors
09/03/2014EP2771327A1 Novel pyrazine derivatives
09/03/2014EP2771325A1 Pyridazine derivatives useful in therapy
09/03/2014EP2771324A1 Myxovirus therapeutics, compounds, and uses related thereto
09/03/2014EP2771069A2 Inhibiting g protein coupled receptor 6 kinase polypeptides
09/02/2014US8822699 Heterocyclic compound and use thereof
09/02/2014US8822685 2,4-pyrimidinediamine compounds and their uses
09/02/2014US8822684 Compounds and methods useful for directing stem cell differentiation
09/02/2014US8822522 Dual-acting pyrazole antihypertensive agents
09/02/2014US8822520 Substituted bicyclic HCV inhibitors
09/02/2014US8822515 Heterocyclic benzoxazole compositions as inhibitors of hepatitis C virus
09/02/2014US8822514 Multi-cyclic compounds and methods of use
09/02/2014US8822513 Compounds for treatment of cancer
09/02/2014US8822511 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
09/02/2014US8822510 Substituted 3-phenyl-1,2,4-Oxadiazole compounds
09/02/2014US8822502 Insecticidal compounds
09/02/2014US8822495 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
09/02/2014US8822486 Spiropiperidine compounds
09/02/2014US8822472 Piperazines, pharmaceutical compositions and methods of use thereof
09/02/2014US8822471 Compounds, pharmaceutical compositions and uses thereof
09/02/2014US8822466 Isoxazole derivatives
09/02/2014US8822464 N-aryl-piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors
09/02/2014US8822458 Substituted oxazolidinones and their use in the field of blood coagulation
09/02/2014US8822452 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
09/02/2014US8822449 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
09/02/2014US8822446 Pyrrolopyridine inhibitors of kinases
09/02/2014US8822430 Antiviral compounds
09/02/2014US8822414 Heterocyclic compounds suitable for the treatment of dyslipidemia
09/02/2014US8822193 Isolated bacterial strain of the genus Burkholderia and pesticidal metabolites therefrom
09/02/2014CA2776242C Phenyloxadiazole derivatives as pgds inhibitors
08/2014
08/28/2014WO2014130470A1 Cis-morpholinone and other compounds as mdm2 inhibitors for the treatment of cancer
08/28/2014WO2014130310A1 Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
08/28/2014WO2014129796A1 Sphingosine-1-phosphate receptor agonists, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
08/28/2014WO2014128612A1 Quinazolin-4-one derivatives
08/28/2014WO2014128486A1 Pyrimidine compounds useful in the treatment of diseases mediated by ikke and/or tbk1 mechanisms
08/28/2014WO2014128022A1 Convenient process for the preparation of statins
08/28/2014WO2014093230A3 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
08/28/2014US20140243524 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
08/28/2014US20140243366 Compounds that modulate intracellular calcium
08/28/2014US20140243353 5- or 6-substituted 3-hydroxy-2(1h)-pyridinones as d-amino acid oxidase (daao) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and paid
08/28/2014US20140243333 Synthesis of functionalized octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
08/28/2014US20140243325 1,3-Oxazines as Bace1 and/or Bace2 Inhibitors
08/28/2014US20140243324 Use of hematopoietic growth factor mimetics
08/28/2014US20140243310 Bicyclic compound
08/28/2014US20140243288 Fused ring-containing oxazolidinones antibiotics
08/28/2014US20140242120 Substituted aromatic compounds for inflammation and immune-related uses
08/27/2014EP2769979A1 Process for the preparation of key intermediates for the synthesis of Statins
08/27/2014EP2768827A1 Process for the preparation of isoxazolyl-methoxy-nicotinic acids
08/27/2014EP2768826A1 Substituted oxadiazolyl pyridinones and oxadiazolyl pyridazinones as hif inhibitors
08/27/2014EP2768823A1 2-pyridyloxy-4-nitrile orexin receptor antagonists
08/27/2014EP2768822A2 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
08/27/2014EP2768813A1 Quinazoline derivatives as pi3k modulators
08/27/2014EP2768809A1 Pyridine- sulfoximines as tyrosine kinase inhibitors
08/27/2014EP2768796A1 Process for preparing quinoline derivatives
08/26/2014US8816079 Amide derivative and use thereof as medicine
08/26/2014US8816072 Process for the preparation of crystalline aprepitant having form I content
08/26/2014US8815924 Heterocyclic carbonyl compounds
08/26/2014US8815905 Propionic acids, propionic acid esters, and related compounds
08/26/2014US8815903 Indole derivative and pharmacologically acceptable salt thereof
08/26/2014US8815864 Indanyloxydihydrobenzofuranylacetic acids
08/26/2014US8815857 Soluble guanylate cyclase activators
08/26/2014US8815856 Crystalline forms of (3R, 6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione
08/26/2014US8815855 N-sulphonylpyrroles and their use as histone deacetylase inhibitors
08/26/2014US8815854 Substituted imidazopyridinyl compounds
08/26/2014US8815853 Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
08/26/2014US8815840 Carbazole and carboline kinase inhibitors
08/26/2014CA2611443C Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
08/26/2014CA2584295C Spiro-2, 4-pyrimidinediamine compounds and their uses
08/21/2014WO2014127195A1 3,5-disubstituted-4,5-dihydro-1,2,4-oxadiazoles for controlling nematode pests
08/21/2014WO2014127152A1 Substituted pyrazole azetidines as sphingosine receptor modulators
08/21/2014WO2014127149A1 Substituted 4,5-dihydropyrazole-1,2,4-oxadiazole derivatives as sphingosine receptor modulators
08/21/2014WO2014127141A1 Substituted 1h-pyrazol-1,2,4-oxadiazole derivatives as sphingosine receptor modulators
08/21/2014WO2014125444A1 Heterocyclic amides as kinase inhibitors
08/21/2014WO2014096388A3 Novel benzimidazole derivatives as kinase inhibitors
08/21/2014US20140235868 Novel antithrombotic and antiatherosclerotic agent and method for producing same (variants)
08/21/2014US20140235673 Pyridinedione carboxamide inhibitors of endothelial lipase
08/21/2014US20140235660 Compounds and compositions as selective estrogen receptor degraders
08/21/2014US20140235652 Pyridine Derivatives
08/21/2014US20140235647 Substituted bicyclic heteroaryl compounds
08/21/2014US20140235642 Trpm8 antagonists and their use in treatments
08/21/2014US20140235641 Pyrazole carboxamides as janus kinase inhibitors
08/21/2014US20140235640 Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 647